ARCHIVES

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

This article is from The Cancer Letter archive.

Vol. 24 No. 14 | April 10, 1998

Download PDF Visit The Full Archive

Related Articles

Risks Of Long-Term HRT Outweigh Benefits, WHI Finds

March 28, 2008

Advisors suggest NCI establish sarcoma research consortium.

January 30, 2004

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

UPCI wins NCI SPORE grant for head and neck cancer.

September 24, 2004

In Brief: PCORI Forms Clinical Trials Advisory Board

April 4, 2014